Abstract
Purpose of Review
This review discusses the outcomes of percutaneous coronary intervention (PCI) in women who experience acute myocardial infarction (AMI) and are treated with drug-eluting stents (DES). The review also describes the role of the new-generation DES compared with the early generation.
Recent Findings
Recent literature shows that the new-generation DES can be effective in women who present with AMI.
Summary
Women with AMI may be undertreated and are underrepresented in studies of AMI. Recently, it has been shown that the newer generation DES are effective and beneficial in women with AMI, similar to men. As further generations of DES are created, the future appears promising for continued advancements in women’s cardiovascular health.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Yu J, Mehran R, Grinfeld L, Xu K, Nikolsky E, Brodie BR, et al. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv. 2015;85(3):359–68. https://doi.org/10.1002/ccd.25630.
Pancholy SB, Shantha GP, Patel T, Cheskin LJ. Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis. JAMA Intern Med. 2014;174(11):1822–30. https://doi.org/10.1001/jamainternmed.2014.4762.
• Udell JA, Fonarow GC, Maddox TM, Cannon CP, Frank Peacock W, Laskey WK, et al. Sustained sex-based treatment differences in acute coronary syndrome care: insights from the American Heart Association Get With The Guidelines Coronary Artery Disease Registry. Clin Cardiol. 2018;41(6):758–68. https://doi.org/10.1002/clc.22938 Important recent study which provides the results of the sex-based difference in ACS treatment.
•• Giustino G, Harari R, Baber U, Sartori S, Stone GW, Leon MB, et al. Long-term safety and efficacy of new-generation drug-eluting stents in women with acute myocardial infarction: from the Women in Innovation and Drug-Eluting Stents (WIN-DES) collaboration. JAMA Cardiol. 2017;2(8):855–62. https://doi.org/10.1001/jamacardio.2017.1978 Very important recent study which provides the evidence of the efficacy of new-generation DES in women with AMI.
Kerkmeijer LS, Claessen BE, Baber U, Sartori S, Chandrasekhar J, Stefanini GG, et al. Incidence, determinants and clinical impact of definite stent thrombosis on mortality in women: from the WIN-DES collaborative patient-level pooled analysis. Int J Cardiol. 2018;263:24–8. https://doi.org/10.1016/j.ijcard.2018.04.047.
Chandrasekhar J, Baber U, Sartori S, Stefanini GG, Sarin M, Vogel B, et al. Effect of increasing stent length on 3-year clinical outcomes in women undergoing percutaneous coronary intervention with new-generation drug-eluting stents: patient-level pooled analysis of randomized trials from the WIN-DES initiative. JACC Cardiovasc Interv. 2018;11(1):53–65. https://doi.org/10.1016/j.jcin.2017.11.020.
Srinivas VS, Garg S, Negassa A, Bang JY, Monrad ES. Persistent sex difference in hospital outcome following percutaneous coronary intervention: results from the New York State reporting system. J Invasive Cardiol. 2007;19(6):265–8.
Lichtman JH, Wang Y, Jones SB, Leifheit-Limson EC, Shaw LJ, Vaccarino V, et al. Age and sex differences in inhospital complication rates and mortality after percutaneous coronary intervention procedures: evidence from the NCDR((R)). Am Heart J. 2014;167(3):376–83. https://doi.org/10.1016/j.ahj.2013.11.001.
Chandrasekhar J, Baber U, Sartori S, Faggioni M, Aquino M, Kini A, et al. Sex-related differences in outcomes among men and women under 55 years of age with acute coronary syndrome undergoing percutaneous coronary intervention: results from the PROMETHEUS study. Catheter Cardiovasc Interv. 2017;89(4):629–37. https://doi.org/10.1002/ccd.26606.
Peterson ED, Lansky AJ, Kramer J, Anstrom K, Lanzilotta MJ, National Cardiovascular Network Clinical I. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol. 2001;88(4):359–64.
Kunadian V, Qiu W, Lagerqvist B, Johnston N, Sinclair H, Tan Y, et al. Gender differences in outcomes and predictors of all-cause mortality after percutaneous coronary intervention (data from United Kingdom and Sweden). Am J Cardiol. 2017;119(2):210–6. https://doi.org/10.1016/j.amjcard.2016.09.052.
Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A et al. Outcomes of women and men with acute coronary syndrome treated with and without percutaneous coronary revascularization. J Am Heart Assoc. 2017;6(1). https://doi.org/10.1161/JAHA.116.004319.
Khera S, Kolte D, Gupta T, Subramanian KS, Khanna N, Aronow WS, et al. Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States. J Am Coll Cardiol. 2015;66(18):1961–72. https://doi.org/10.1016/j.jacc.2015.08.865.
Josiah A, Farshid A. Gender is not a predictor of mortality or major adverse cardiovascular events in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Heart Lung Circ. 2018. https://doi.org/10.1016/j.hlc.2018.03.020.
Giustino G, Baber U, Stefanini GG, Aquino M, Stone GW, Sartori S, et al. Impact of clinical presentation (stable angina pectoris vs unstable angina pectoris or non-ST-elevation myocardial infarction vs ST-elevation myocardial infarction) on long-term outcomes in women undergoing percutaneous coronary intervention with drug-eluting stents. Am J Cardiol. 2015;116(6):845–52. https://doi.org/10.1016/j.amjcard.2015.06.010.
Giustino G, Baber U, Aquino M, Sartori S, Stone GW, Leon MB, et al. Safety and efficacy of new-generation drug-eluting stents in women undergoing complex percutaneous coronary artery revascularization: from the WIN-DES collaborative patient-level pooled analysis. JACC Cardiovasc Interv. 2016;9(7):674–84. https://doi.org/10.1016/j.jcin.2015.12.013.
Giustino G, Mastoris I, Baber U, Sartori S, Stone GW, Leon MB, et al. Correlates and impact of coronary artery calcifications in women undergoing percutaneous coronary intervention with drug-eluting stents: from the Women in Innovation and Drug-Eluting Stents (WIN-DES) collaboration. JACC Cardiovasc Interv. 2016;9(18):1890–901. https://doi.org/10.1016/j.jcin.2016.06.022.
Giustino G, Baber U, Salianski O, Sartori S, Stone GW, Leon MB, et al. Safety and efficacy of new-generation drug-eluting stents in women at high risk for atherothrombosis: from the Women in Innovation and Drug-Eluting Stents collaborative patient-level pooled analysis. Circ Cardiovasc Interv. 2016;9(1):e002995. https://doi.org/10.1161/CIRCINTERVENTIONS.115.002995.
Amsterdam EA, Wenger NK, Brindis RG, Casey DE Jr, Ganiats TG, Holmes DR Jr, et al. 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130(25):2354–94. https://doi.org/10.1161/CIR.0000000000000133.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Subrata Kar declares that he has no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Ischemic Heart Disease
Rights and permissions
About this article
Cite this article
Kar, S. Outcomes of New-Generation Drug-Eluting Stents in Women with Acute Myocardial Infarction. Curr Cardiol Rep 21, 2 (2019). https://doi.org/10.1007/s11886-019-1087-y
Published:
DOI: https://doi.org/10.1007/s11886-019-1087-y